STOCK TITAN

Keros Therapeutics (KROS) sees 2.7% stake by Madison Avenue group

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Madison Avenue International LP and affiliated entities reported a passive ownership stake in Keros Therapeutics, Inc. common stock. As of February 17, 2026, they beneficially owned 823,707 shares of Common Stock, representing about 2.7% of the company, based on 30,466,069 shares outstanding as of October 31, 2025.

The filing lists Madison Avenue International LP, Madison Avenue Partners, LP, EMAI Management, LLC, Madison Avenue GP, LLC, Caraway Jackson Investments LLC and Eli Samaha, who may each be deemed beneficial owners through their roles in the investment structure. They certify the shares are not held to change or influence control of Keros Therapeutics.

Positive

  • None.

Negative

  • None.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Madison Avenue International LP
Signature:/s/ Eli Samaha
Name/Title:Eli Samaha, as Manager of Madison Avenue GP, LLC, the General Partner of Madison Avenue International LP
Date:02/17/2026
Madison Avenue Partners, LP
Signature:/s/ Eli Samaha
Name/Title:Eli Samaha, as Managing Member of EMAI Management, LLC, the General Partner of Madison Avenue Partners, LP
Date:02/17/2026
EMAI Management, LLC
Signature:/s/ Eli Samaha
Name/Title:Eli Samaha, as Managing Member
Date:02/17/2026
Madison Avenue GP, LLC
Signature:/s/ Eli Samaha
Name/Title:Eli Samaha, as Manager
Date:02/17/2026
Caraway Jackson Investments LLC
Signature:/s/ Eli Samaha
Name/Title:Eli Samaha, as Member
Date:02/17/2026
Eli Samaha
Signature:/s/ Eli Samaha
Name/Title:ELI SAMAHA
Date:02/17/2026